Polskie Archiwum Medycyny Wewnętrznej
-
Pol. Arch. Med. Wewn. · Feb 2021
Ten-year changes in adherence to a healthy lifestyle: the results of the WOBASZ Surveys.
The evidence on the beneficial role of low‑risk characteristics is well established. However, data on trends in lifestyle patterns in Central Europe are limited. ⋯ The ultimate goal for the healthcare system should be to implement more effective interventions focused on promoting healthy lifestyle as a whole.
-
Pol. Arch. Med. Wewn. · Feb 2021
Cost-effectiveness of colonoscopy in the organized screening program.
Colorectal cancer (CRC) is a serious health problem, and various screening programs to reduce CRC have been introduced worldwide. However, the cost‑effectiveness of a program based on once‑in‑a‑lifetime colonoscopy in Poland is unknown. ⋯ Colonoscopy screening within the PCSP is cost‑effective and may have a substantial impact on the Polish society due to life‑years saved. The results have good informative value not only for health policy makers and medical practitioners, but also for health technology assessment.
-
Pol. Arch. Med. Wewn. · Feb 2021
Comparison of transcatheter aortic valve implantation outcomes in patients aged.
The number of elderly patients requiring treatment of aortic stenosis is expected to grow steadily due to increasing lifespan. Transcatheter aortic valve implantation (TAVI) is an alternative treat‑ ment for patients with aortic stenosis considered nonoptimal candidates for surgical valve replacement. ⋯ Cardiovascular mortality at 1 month and 1 year following TAVI is similar in patients aged 85 years or older and in those younger than 85 years.
-
Pol. Arch. Med. Wewn. · Feb 2021
Association between peripheral eosinophils and clinical outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Programmed cell death ligand 1 is considered a predictor of the therapeutic effect of immune checkpoint inhibitors (ICPIs), but a more simple and useful predictor is needed. ⋯ The measurement of peripheral eosinophils up to around 5 weeks following the initiation of treatment, especially the maximum eosinophils count and percentage, might provide useful information about the efficacy of ICPIs.